Could the body’s own immune system play a role in memory impairment and cognitive dysfunction associated with conditions like chronic epilepsy, Alzheimer’s dementia and concussions?.
The study focuses on the role of a protein known as S100B, which serves as a biomarker for brain damage. Normally, S100B is found only in the brain and spinal column. However, following a brain injury, it can leak through the blood-brain barrier into the blood. Once S100B enters the bloodstream, it is identified as an intruder by the immune system, which releases antibodies to attack the protein.
The results show an unexpected role for S100B in the regulation of a neuro-immune response, connecting the function of the brain to the immune system. Uptake of S100B was prominent in cells that are known to be involved in regulating immune responses. Repeated increases of S100B, whether due to epileptic seizures, Alzheimer’s disease, or repeated hits to the head in sporting events, may thus become boosters of an autoimmune response against the brain, which may slowly but inexorably result in chronic neurological disease. These findings are the first to report a connection between a brain-derived protein and an immune response in the context of normal immunological function.
Prior to this research, S100B autoantibodies have been described in a variety of diseases, primarily in Alzheimer’s dementia and chronic epilepsy. More recently, repeated subconcussive episodes in football players included a post-game increase of S100B, followed by an autoimmune response against the protein. Therefore, it appears that autoimmunity against brain proteins may be one of the initial steps in the progression towards posttraumatic cognitive decline.
The study tested the hypothesis that the presence of S100B in extracranial tissue is due to the production of antigen-presenting cells in the blood, which may induce the production of auto-antibodies against S100B. To test this hypothesis, researchers used animal models of seizures, enrolled patients undergoing repeated disruption of the blood-brain barrier, and collected blood samples from epileptic patients.
If further research confirms the study’s findings, treatments for brain injury may include anti-inflammatory therapy or immunomodulators to decrease the autoimmune response, as has been done in the treatment of multiple sclerosis and myasthenia gravis.
Janigro holds two U.S. patents on the use of S100B as a marker of blood-brain barrier disruption.
Source: The Cleveland Clinic
alzheimer's, BBB, biomarker, blood-brain barrier, brain trauma, dementia, diagnostic, epilepsy, glioblastoma, healthinnovations, lou gehrig's disease, memory, neuro-immune, neurobiology, neurodegeneration, neurodegenerative, neuroinnovations, neurology, neuroprotection, neuropsychiatry, neuroscience
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.